Additionally, key proteins in the AKT-mTOR and ERK1/2 pathways and PD-L1 further confirmed that ZMF-25 inhibited tumor growth by blocking PAK1 and HDAC class IIb-mediated cell growth mechanisms (Fig. 11M to O). Here, HDAC9 is linked to neoplasm.